Epigenetic regulation of the miR142-3p/interleukin-6 circuit in glioblastoma

Molecular Cell

Volumn 52, Issue 5, 2013, Pages 693-706

  Chiou, Guang Yuh ^a,b   Chien, Chian Shiu ^a   Wang, Mong Lien ^a   Chen, Ming Teh ^a,b   Yang, Yi Ping ^a   Yu, Yung Luen ^e,f   Chien, Yueh ^a,b   Chang, Yun Ching ^a,b   Shen, Chiung Chyi ^a,c   Chio, Chung Ching ^d   Lu, Kai Hsi ^g   Ma, Hsin I ^h   Chen, Kuan Hsuan ^a,b   Liu, Dean Mo ⁱ   Miller, Stephanie A ^j   Chen, Yi Wei ^a,b   Huang, Pin I ^a,b   Shih, Yang Hsin ^a,b   Hung, Mien Chie ^e,f,j   Chiou, Shih Hwa ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

^g CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^h TRI SERVICE GENERAL HOSPITAL   (Taiwan)

ⁱ NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^j UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DNA METHYLTRANSFERASE 1; INTERLEUKIN 6; MICRORNA; MIRNA 142 3P; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CANCER GROWTH; CARCINOGENICITY; CONTROLLED STUDY; CYTOKINE RELEASE; DNA METHYLATION; GENETIC REGULATION; GENOTYPE; GLIOBLASTOMA; HUMAN; IMMUNE DEFICIENCY; MOUSE; NEURAL STEM CELL; NONHUMAN; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; SURVIVAL; TUMOR MICROENVIRONMENT;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BRAIN NEOPLASMS; CELL LINE, TUMOR; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GLIOBLASTOMA; HMGA2 PROTEIN; HUMANS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; SOXB1 TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84890226018     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.11.009     Document Type: Article

References (41)

1. Bostick M., Kim J.K., Estève P.O., Clark A., Pradhan S., Jacobsen S.E. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007, 317:1760-1764.
2. Braconi C., Huang N., Patel T. MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 2010, 51:881-890.
3. Chen C.Z., Li L., Lodish H.F., Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86.
4. De Martino I., Visone R., Wierinckx A., Palmieri D., Ferraro A., Cappabianca P., Chiappetta G., Forzati F., Lombardi G., Colao A., et al. HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. Cancer Res. 2009, 69:1844-1850.
5. Deng G., Song G.A., Pong E., Sleisenger M., Kim Y.S. Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor. Cancer Res. 2004, 64:2692-2698.
6. Estève P.O., Chin H.G., Pradhan S. Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. Proc. Natl. Acad. Sci. USA 2005, 102:1000-1005.
7. Estève P.O., Chin H.G., Pradhan S. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells. J.Biol. Chem. 2007, 282:2615-2625.
8. Foran E., Garrity-Park M.M., Mureau C., Newell J., Smyrk T.C., Limburg P.J., Egan L.J. Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6. Mol. Cancer Res. 2010, 8:471-481.
9. Gangemi R.M., Griffero F., Marubbi D., Perera M., Capra M.C., Malatesta P., Ravetti G.L., Zona G.L., Daga A., Corte G. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 2009, 27:40-48.
10. Gillies J.K., Lorimer I.A. Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle 2007, 6:2005-2009.
11. Gopisetty G., Xu J., Sampath D., Colman H., Puduvalli V.K. Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation. Oncogene 2013, 32:3119-3129.
12. Guan H., Cai J., Zhang N., Wu J., Yuan J., Li J., Li M. Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome. Int. J. Cancer 2012, 130:593-601.
13. Hermansen S.K., Kristensen B.W. MicroRNA biomarkers in glioblastoma. J.Neurooncol. 2013, 114:13-23.
14. Hervouet E., Vallette F.M., Cartron P.F. Dnmt1/Transcription factor interactions: an alternative mechanism of DNA methylation inheritance. Genes Cancer 2010, 1:434-443.
15. Iliopoulos D., Hirsch H.A., Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009, 139:693-706.
16. Inda M.M., Bonavia R., Mukasa A., Narita Y., Sah D.W., Vandenberg S., Brennan C., Johns T.G., Bachoo R., Hadwiger P., et al. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev. 2010, 24:1731-1745.
17. Kim E., Kim M., Woo D.H., Shin Y., Shin J., Chang N., Oh Y.T., Kim H., Rheey J., Nakano I., et al. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell 2013, 23:839-852.
18. Korkaya H., Kim G.I., Davis A., Malik F., Henry N.L., Ithimakin S., Quraishi A.A., Tawakkol N., D'Angelo R., Paulson A.K., et al. Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. Mol. Cell 2012, 47:570-584.
19. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W., et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9:391-403.
20. Meng F., Wehbe-Janek H., Henson R., Smith H., Patel T. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene 2008, 27:378-386.
21. Møller H.G., Rasmussen A.P., Andersen H.H., Johnsen K.B., Henriksen M., Duroux M. A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion. Mol. Neurobiol. 2013, 47:131-144.
22. Noushmehr H., Weisenberger D.J., Diefes K., Phillips H.S., Pujara K., Berman B.P., Pan F., Pelloski C.E., Sulman E.P., Bhat K.P., et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010, 17:510-522. Cancer Genome Atlas Research Network.
23. Rokavec M., Wu W., Luo J.L. IL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis. Mol. Cell 2012, 45:777-789.
24. Sansone P., Storci G., Tavolari S., Guarnieri T., Giovannini C., Taffurelli M., Ceccarelli C., Santini D., Paterini P., Marcu K.B., et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J.Clin. Invest. 2007, 117:3988-4002.
25. Sen G.L., Reuter J.A., Webster D.E., Zhu L., Khavari P.A. DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature 2010, 463:563-567.
26. Sharif J., Muto M., Takebayashi S., Suetake I., Iwamatsu A., Endo T.A., Shinga J., Mizutani-Koseki Y., Toyoda T., Okamura K., et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007, 450:908-912.
27. Sharma S., Liu J., Wei J., Yuan H., Zhang T., Bishopric N.H. Repression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy. EMBO Mol Med 2012, 4:617-632.
28. Silber J., Lim D.A., Petritsch C., Persson A.I., Maunakea A.K., Yu M., Vandenberg S.R., Ginzinger D.G., James C.D., Costello J.F., et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008, 6:14.
29. Straussman R., Morikawa T., Shee K., Barzily-Rokni M., Qian Z.R., Du J., Davis A., Mongare M.M., Gould J., Frederick D.T., et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 2012, 487:500-504.
30. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., Belanger K., Brandes A.A., Marosi C., Bogdahn U., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N.Engl. J. Med. 2005, 352:987-996. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials GroupNational Cancer Institute of Canada Clinical Trials Group.
31. Stupp R., Hegi M.E., Gilbert M.R., Chakravarti A. Chemoradiotherapy in malignant glioma: standard of care and future directions. J.Clin. Oncol. 2007, 25:4127-4136.
32. Sun Y., Varambally S., Maher C.A., Cao Q., Chockley P., Toubai T., Malter C., Nieves E., Tawara I., Wang Y., et al. Targeting of microRNA-142-3p in dendritic cells regulates endotoxin-induced mortality. Blood 2011, 117:6172-6183.
33. Sun Y., Sun J., Tomomi T., Nieves E., Mathewson N., Tamaki H., Evers R., Reddy P. PU.1-dependent transcriptional regulation of miR-142 contributes to its hematopoietic cell-specific expression and modulation of IL-6. J.Immunol. 2013, 190:4005-4013.
34. Takeshita F., Patrawala L., Osaki M., Takahashi R.U., Yamamoto Y., Kosaka N., Kawamata M., Kelnar K., Bader A.G., Brown D., Ochiya T. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol. Ther. 2010, 18:181-187.
35. Turcan S., Rohle D., Goenka A., Walsh L.A., Fang F., Yilmaz E., Campos C., Fabius A.W., Lu C., Ward P.S., et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 2012, 483:479-483.
36. van Hoesel A.Q., Sato Y., Elashoff D.A., Turner R.R., Giuliano A.E., Shamonki J.M., Kuppen P.J., van de Velde C.J., Hoon D.S. Assessment of DNA methylation status in early stages of breast cancer development. Br. J. Cancer 2013, 108:2033-2038.
37. Wang X.S., Gong J.N., Yu J., Wang F., Zhang X.H., Yin X.L., Tan Z.Q., Luo Z.M., Yang G.H., Shen C., Zhang J.W. MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood 2012, 119:4992-5004.
38. Weissenberger J., Loeffler S., Kappeler A., Kopf M., Lukes A., Afanasieva T.A., Aguzzi A., Weis J. IL-6 is required for glioma development in a mouse model. Oncogene 2004, 23:3308-3316.
39. Wu L., Cai C., Wang X., Liu M., Li X., Tang H. MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett. 2011, 585:1322-1330.
40. Yan H., Parsons D.W., Jin G., McLendon R., Rasheed B.A., Yuan W., Kos I., Batinic-Haberle I., Jones S., Riggins G.J., et al. IDH1 and IDH2 mutations in gliomas. N.Engl. J. Med. 2009, 360:765-773.
41. Yang Y.P., Chien Y., Chiou G.Y., Cherng J.Y., Wang M.L., Lo W.L., Chang Y.L., Huang P.I., Chen Y.W., Shih Y.H., et al. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. Biomaterials 2012, 33:1462-1476.